Refana

News

  • Home
  • Narcotic ID
    • Grant Funding
  • Research
  • Team
  • About
  • Blog

3/8/2021

Sinovac’s vaccine shows an 80-90% efficacy rate within 2 months after 2 shots: CEO

0 Comments

Read Now
 
Picture
As one of the leading COVID-19 vaccine manufacturers in China, Sinovac has expanded its annual production capacity to 2 billion doses and offered its inactivated vaccines to over 16 countries and regions. The Global Times reporters Hu Yuwei and Leng Shumei (GT) recently talked to Yin Weidong (Yin), the CEO of the Sinovac, to learn more about his views on vaccine's safety and effectiveness, amid frequently novel coronavirus mutations, and the company's moves in making the vaccine more globally accessible. 

​Read the interview here.
​

Share

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

Details

    Categories

    All
    Artificial Intelligence
    Blood Testing
    Covid 19
    Early Cancer Detection
    Imaging
    Narcotics
    Press Release

    Archives

    February 2025
    June 2024
    January 2024
    December 2023
    November 2023
    October 2023
    April 2023
    January 2023
    November 2022
    September 2022
    July 2022
    May 2022
    April 2022
    March 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    July 2020
    June 2020

    RSS Feed

​Practical Solutions for Complex and ​Urgent Global Problems

HOME     |     PROGRAMS    |    RESEARCH   |   TEAM     |     ABOUT     |     BLOG
Privacy Policy | Cookie Policy
© 2025 Refana Inc
  • Home
  • Narcotic ID
    • Grant Funding
  • Research
  • Team
  • About
  • Blog